Ribociclib Reduces Risk of Recurrence for High-Risk Node-Negative Breast Cancer
The latest analysis from the phase III NATALEE trial demonstrated that adding ribociclib (Kisqali) to endocrine therapy improved rates of ...
Read moreDetails
Tag: Ribociclib
The Earth News is an independent English-language daily published Website from all around the World News
